• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Can ivermectin mass drug administrations to control scabies also reduce skin and soft tissue infections? Hospitalizations and primary care presentations lower after a large-scale trial in Fiji.

作者信息

Middleton Jo

机构信息

NIHR Global Health Research Unit on Neglected Tropical Diseases and Department of Primary Care and Public Health, Brighton and Sussex Medical School, Falmer, United Kingdom.

Evolution, Behavior and Environment, School of Life Sciences, University of Sussex, Falmer, East Sussex, United Kingdom.

出版信息

Lancet Reg Health West Pac. 2022 Apr 11;22:100454. doi: 10.1016/j.lanwpc.2022.100454. eCollection 2022 May.

DOI:10.1016/j.lanwpc.2022.100454
PMID:35462879
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9018377/
Abstract
摘要

相似文献

1
Can ivermectin mass drug administrations to control scabies also reduce skin and soft tissue infections? Hospitalizations and primary care presentations lower after a large-scale trial in Fiji.用伊维菌素进行群体药物给药以控制疥疮，是否也能减少皮肤和软组织感染？在斐济进行的一项大规模试验后，住院率和初级保健就诊率有所降低。
Lancet Reg Health West Pac. 2022 Apr 11;22:100454. doi: 10.1016/j.lanwpc.2022.100454. eCollection 2022 May.
2
Prevention of bacterial complications of scabies using mass drug administration: A population-based, before-after trial in Fiji, 2018-2020.通过群体药物给药预防疥疮的细菌并发症：2018 - 2020年在斐济进行的一项基于人群的前后对照试验。
Lancet Reg Health West Pac. 2022 Mar 22;22:100433. doi: 10.1016/j.lanwpc.2022.100433. eCollection 2022 May.
3
Costs of primary healthcare presentations and hospital admissions for scabies and related skin infections in Fiji, 2018-2019.2018 - 2019年斐济疥疮及相关皮肤感染的初级医疗就诊和住院费用
PLOS Glob Public Health. 2024 Oct 10;4(10):e0003706. doi: 10.1371/journal.pgph.0003706. eCollection 2024.
4
Prospective Surveillance of Primary Healthcare Presentations for Scabies and Bacterial Skin Infections in Fiji, 2018-2019.2018-2019 年斐济原发性皮肤病（疥疮和细菌性皮肤感染）的初级保健前瞻性监测。
Am J Trop Med Hyg. 2021 May 24;105(1):230-237. doi: 10.4269/ajtmh.20-1459.
5
Mass Drug Administration for Scabies Control in a Population with Endemic Disease.群体疥疮疾病控制中的大规模药物治疗。
N Engl J Med. 2015 Dec 10;373(24):2305-13. doi: 10.1056/NEJMoa1500987.
6
Costs of mass drug administration for scabies in Fiji.在斐济，大规模药物治疗疥疮的成本。
PLoS Negl Trop Dis. 2022 Feb 3;16(2):e0010147. doi: 10.1371/journal.pntd.0010147. eCollection 2022 Feb.
7
Community control strategies for scabies: A cluster randomised noninferiority trial.社区疥疮控制策略：一项集群随机非劣效性试验。
PLoS Med. 2021 Nov 10;18(11):e1003849. doi: 10.1371/journal.pmed.1003849. eCollection 2021 Nov.
8
Hospital admissions for skin and soft tissue infections in a population with endemic scabies: A prospective study in Fiji, 2018-2019.在一个疥疮流行的人群中，因皮肤和软组织感染而住院的情况：2018-2019 年斐济的一项前瞻性研究。
PLoS Negl Trop Dis. 2020 Dec 9;14(12):e0008887. doi: 10.1371/journal.pntd.0008887. eCollection 2020 Dec.
9
The safety of combined triple drug therapy with ivermectin, diethylcarbamazine and albendazole in the neglected tropical diseases co-endemic setting of Fiji: A cluster randomised trial.在斐济被忽视热带病流行地区联合使用伊维菌素、乙胺嗪和阿苯达唑三联药物治疗的安全性：一项集群随机试验。
PLoS Negl Trop Dis. 2020 Mar 16;14(3):e0008106. doi: 10.1371/journal.pntd.0008106. eCollection 2020 Mar.
10
Scabies community prevalence and mass drug administration in two Fijian villages.斐济两个村庄的疥疮社区患病率及群体药物给药情况
Int J Dermatol. 2014 Jun;53(6):739-45. doi: 10.1111/ijd.12353. Epub 2013 Oct 29.

引用本文的文献

1
The disability-adjusted life years (DALYs), prevalence and incidence of scabies, 1990-2021: A systematic analysis from the Global Burden of Disease Study 2021.1990 - 2021年疥疮的伤残调整生命年（DALYs）、患病率和发病率：来自《2021年全球疾病负担研究》的系统分析
PLoS Negl Trop Dis. 2024 Dec 26;18(12):e0012775. doi: 10.1371/journal.pntd.0012775. eCollection 2024 Dec.
2
Scabies outbreak management in refugee/migrant camps in Europe 2014-2017: a retrospective qualitative interview study of healthcare staff experiences and perspectives.2014-2017 年欧洲难民营/移民营中的疥疮疫情管理：对医护人员的经验和观点的回顾性定性访谈研究。
BMJ Open. 2023 Nov 8;13(11):e075103. doi: 10.1136/bmjopen-2023-075103.
3
Scabies in the Amhara region of northern Ethiopia: a cross-sectional study of prevalence, determinants, clinical presentation and community knowledge.埃塞俄比亚北部阿姆哈拉地区的疥疮：患病率、决定因素、临床特征和社区知识的横断面研究。
BMJ Open. 2023 Oct 25;13(10):e075038. doi: 10.1136/bmjopen-2023-075038.
4
Health service needs and perspectives of a rainforest conserving community in Papua New Guinea's Ramu lowlands: a combined clinical and rapid anthropological assessment with parallel treatment of urgent cases.巴布亚新几内亚拉穆低地雨林保护区社区的卫生服务需求和观点：临床与快速人类学评估相结合，并同时处理紧急病例。
BMJ Open. 2023 Oct 6;13(10):e075946. doi: 10.1136/bmjopen-2023-075946.
5
Scabies incidence and association with skin and soft tissue infection in Loyalty Islands Province, New Caledonia: A 15-year retrospective observational study using electronic health records.疥疮发病率与新喀里多尼亚洛亚蒂群岛省皮肤和软组织感染的关联性：使用电子健康记录的 15 年回顾性观察研究。
PLoS Negl Trop Dis. 2022 Sep 6;16(9):e0010717. doi: 10.1371/journal.pntd.0010717. eCollection 2022 Sep.

本文引用的文献

1
Prevention of bacterial complications of scabies using mass drug administration: A population-based, before-after trial in Fiji, 2018-2020.通过群体药物给药预防疥疮的细菌并发症：2018 - 2020年在斐济进行的一项基于人群的前后对照试验。
Lancet Reg Health West Pac. 2022 Mar 22;22:100433. doi: 10.1016/j.lanwpc.2022.100433. eCollection 2022 May.
2
A framework for scabies control.疥疮控制框架。
PLoS Negl Trop Dis. 2021 Sep 2;15(9):e0009661. doi: 10.1371/journal.pntd.0009661. eCollection 2021 Sep.
3
Scabies and impetigo in Samoa: A school-based clinical and molecular epidemiological study.萨摩亚的疥疮和脓疱病：一项基于学校的临床与分子流行病学研究。
Lancet Reg Health West Pac. 2020 Dec 29;6:100081. doi: 10.1016/j.lanwpc.2020.100081. eCollection 2021 Jan.
4
"Stopping the itch": mass drug administration for scabies outbreak control covered for over nine million people in Ethiopia.“止痒行动”：埃塞俄比亚为超过 900 万人实施大规模药物治疗，以控制疥疮疫情。
J Infect Dev Ctries. 2020 Jun 29;14(6.1):28S-35S. doi: 10.3855/jidc.11701.
5
Prevalence of Scabies and Impetigo 3 Years After Mass Drug Administration With Ivermectin and Azithromycin.使用伊维菌素和阿奇霉素进行大规模药物给药3年后疥疮和脓疱病的患病率
Clin Infect Dis. 2020 Apr 10;70(8):1591-1595. doi: 10.1093/cid/ciz444.
6
Scabies control: the forgotten role of personal hygiene - Authors' reply.疥疮防治：个人卫生被遗忘的作用——作者回复
Lancet Infect Dis. 2018 Oct;18(10):1068-1069. doi: 10.1016/S1473-3099(18)30558-9.
7
Mass Drug Administration for Scabies Control in a Population with Endemic Disease.群体疥疮疾病控制中的大规模药物治疗。
N Engl J Med. 2015 Dec 10;373(24):2305-13. doi: 10.1056/NEJMoa1500987.
8
Long Term Control of Scabies Fifteen Years after an Intensive Treatment Programme.强化治疗方案实施十五年后疥疮的长期控制
PLoS Negl Trop Dis. 2015 Dec 1;9(12):e0004246. doi: 10.1371/journal.pntd.0004246. eCollection 2015 Dec.
9
Impact of an Ivermectin Mass Drug Administration on Scabies Prevalence in a Remote Australian Aboriginal Community.伊维菌素群体给药对澳大利亚偏远原住民社区疥疮患病率的影响。
PLoS Negl Trop Dis. 2015 Oct 30;9(10):e0004151. doi: 10.1371/journal.pntd.0004151. eCollection 2015 Oct.
10
Prevalence of scabies and impetigo worldwide: a systematic review.全球范围内疥疮和脓疱疮的患病率：系统评价。
Lancet Infect Dis. 2015 Aug;15(8):960-7. doi: 10.1016/S1473-3099(15)00132-2. Epub 2015 Jun 15.